Fekrirad, Z.; Barzegar Behrooz, A.; Ghaemi, S.; Khosrojerdi, A.; Zarepour, A.; Zarrabi, A.; Arefian, E.; Ghavami, S.
Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. Cancers 2022, 14, 3698.
https://doi.org/10.3390/cancers14153698
AMA Style
Fekrirad Z, Barzegar Behrooz A, Ghaemi S, Khosrojerdi A, Zarepour A, Zarrabi A, Arefian E, Ghavami S.
Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. Cancers. 2022; 14(15):3698.
https://doi.org/10.3390/cancers14153698
Chicago/Turabian Style
Fekrirad, Zahra, Amir Barzegar Behrooz, Shokoofeh Ghaemi, Arezou Khosrojerdi, Atefeh Zarepour, Ali Zarrabi, Ehsan Arefian, and Saeid Ghavami.
2022. "Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy" Cancers 14, no. 15: 3698.
https://doi.org/10.3390/cancers14153698
APA Style
Fekrirad, Z., Barzegar Behrooz, A., Ghaemi, S., Khosrojerdi, A., Zarepour, A., Zarrabi, A., Arefian, E., & Ghavami, S.
(2022). Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. Cancers, 14(15), 3698.
https://doi.org/10.3390/cancers14153698
